Aethlon Medical Inc (AEMD)

Name: Aethlon Medical Inc Financial Statements
Creator: Quarter Results

Healthcare | Medical Devices

Latest reporting period: 2025-12-31

Latest Quarter

2025-12-31

Revenue

$0.0

Net Income

-$2.0M

Operating Margin

N/A

Free Cash Flow

-$7.6M

Debt / Assets

30.4%

Values are in USD and rounded to the nearest whole number unless noted.

Swipe horizontally to view all columns.

Income statement quarterly history for Aethlon Medical Inc (AEMD).
Income Statement (Quarterly)	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Revenue	0	0	0	0
Cost of Revenue	155,516	152,946	154,907	0
Gross Profit	-155,516	-152,946	-154,907	0
Operating Expenses
R&D Expenses	0	0	0	0
SG&A Expenses	1,373,818	1,062,566	1,211,390,000	5,459,935,000
Operating Expenses	1,906,600	1,356,884	1,637,483	2,003,963
Operating Income	-2,062,116	-1,509,830	-1,792,390	7,338,000
Interest Expense	0	0	0	10,109
Income Before Tax	-2,018,244	-1,487,100	-1,761,858	-6,254,893
Income Tax Expense	0	0	0	0
Net Income	-2,018,244	-1,487,100	-1,761,858	-6,254,893
Per Share
EPS	-2.45	-3.74	-8.50	-4.01
EPS Diluted	0.00	0.00	0.00	0.00

Income statement annual history for Aethlon Medical Inc (AEMD).
Income Statement (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Revenue	0	0	574,245	294,165	659,104
Cost of Revenue	0	0	265,300	154,217	0
Gross Profit	0	0	308,945	139,948	0
Operating Expenses
R&D Expenses	0	0	0	0	0
SG&A Expenses	9,341,365	12,636,568	12,473,000	10,715,050	8,549,023
Operating Expenses	9,341,365	12,636,568	12,615,000	10,715,050	0
Operating Income	-9,341,365	-12,636,568	-11,899,000	-10,420,885	-7,889,919
Interest Expense	10,109	0	0	-123,685	1,580
Income Before Tax	-13,388,090	-12,208,174	-12,030,000	-10,420,885	-7,891,499
Income Tax Expense	0	0	0	-4,794	0
Net Income	-13,388,089	-12,208,174	-12,030,000	-10,416,091	-7,886,709
Per Share
EPS	-85.80	-48.60	-5.86	-7.06	-0.65
EPS Diluted	0.00	0.00	0.00	0.00	0.00

Balance sheet quarterly history for Aethlon Medical Inc (AEMD).
Balance Sheet (Quarterly)	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Assets
Cash and Cash Equivalents	5,501,261	5,441,978	14,532,943	17,072,419
Short Term Investments	0	0	0	0
Net Receivables	0	0	0	127,965
Inventory	0	0	0	0
Total Current Assets	5,949,800	6,225,788	15,090,566	18,157,007
Property Plant Equipment	1,278,066	1,898,283	2,295,913	1,137,936
Goodwill and Intangibles	550	1,100	1,650	2,200
Total Assets	7,359,534	8,245,982	17,508,940	19,417,954
Liabilities
Account Payables	534,524	777,862	432,889	499,962
Short Term Debt	313,033	290,565	269,386	126,905
Total Current Liabilities	1,899,286	1,829,899	1,505,088	1,824,049
Long Term Debt	336,718	649,751	939,642	602,505
Total Liabilities	2,236,004	2,479,650	2,444,730	2,426,554
Shareholders Equity
Retained Earnings	-167,954,817	-154,566,728	-142,364,695	-130,329,181
Total Shareholders Equity	5,123,530	5,766,332	15,064,210	17,133,108

Balance sheet annual history for Aethlon Medical Inc (AEMD).
Balance Sheet (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Assets
Cash and Cash Equivalents	5,501,261	5,441,978	14,532,943	17,072,419	9,861,575
Short Term Investments	0	0	0	0	0
Net Receivables	0	0	0	127,965	149,082
Inventory	0	0	0	0	0
Total Current Assets	5,949,800	6,225,788	15,090,566	18,157,007	10,351,738
Property Plant Equipment	1,278,066	1,898,283	2,295,913	1,137,936	201,339
Goodwill and Intangibles	550	1,100	1,650	2,200	56,954
Total Assets	7,359,534	8,245,982	17,508,940	19,417,954	10,668,916
Liabilities
Account Payables	534,524	777,862	432,889	499,962	337,678
Short Term Debt	313,033	290,565	269,386	126,905	42,543
Total Current Liabilities	1,899,286	1,829,899	1,505,088	1,824,049	1,375,226
Long Term Debt	336,718	649,751	939,642	602,505	0
Total Liabilities	2,236,004	2,479,650	2,444,730	2,426,554	1,375,226
Shareholders Equity
Retained Earnings	-167,954,817	-154,566,728	-142,364,695	-130,329,181	-119,913,090
Total Shareholders Equity	5,123,530	5,766,332	15,064,210	17,133,108	9,430,604

Cash flow quarterly history for Aethlon Medical Inc (AEMD).
Cash Flow Statement (Quarterly)	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Operating Activities
Net Income	-13,388,089	-12,208,174	-12,029,786	-10,420,885
Depreciation & Amortization	339,559	359,057	240,892	123,685
Stock Based Compensation	415,234	1,219,370	1,051,898	750,621
Change in Working Capital	93,694	478,659	65,339	-251,110
Operating Cash Flow	-7,645,532	-10,129,810	-10,505,128	-9,767,157
Investing Activities
Capital Expenditure	0	-250,867	-943,109	-349,193
Investments	0	-250,867	-943,109	-349,193
Investing Cash Flow	0	-250,867	-943,109	-349,193
Financing Activities
Debt Repayment	0	0	0	0
Common Stock Issued/Repurchased	3,539,907	1,322,383	8,914,718	17,367,974
Dividends Paid	0	0	0	0
Financing Cash Flow	7,727,384	1,287,605	8,914,718	17,367,974
Summary
Free Cash Flow	-7,645,532	-10,380,677	-11,448,237	-10,116,350
Net Change in Cash	69,590	-9,090,965	-2,539,476	7,251,624

Cash flow annual history for Aethlon Medical Inc (AEMD).
Cash Flow Statement (Annual)	2025-03-31	2024-03-31	2023-03-31	2022-03-31	2021-03-31
Operating Activities
Net Income	-13,388,089	-12,208,174	-12,029,786	-10,420,885	-7,886,709
Depreciation & Amortization	339,559	359,057	240,892	123,685	39,939
Stock Based Compensation	415,234	1,219,370	1,051,898	750,621	779,421
Change in Working Capital	93,694	478,659	65,339	-251,110	309,690
Operating Cash Flow	-7,645,532	-10,129,810	-10,505,128	-9,767,157	-6,764,940
Investing Activities
Capital Expenditure	0	-250,867	-943,109	-349,193	-59,881
Investments	0	-250,867	-943,109	-349,193	-59,881
Investing Cash Flow	0	-250,867	-943,109	-349,193	-59,881
Financing Activities
Debt Repayment	0	0	0	0	0
Common Stock Issued/Repurchased	3,539,907	1,322,383	8,914,718	17,367,974	7,260,869
Dividends Paid	0	0	0	0	0
Financing Cash Flow	7,727,384	1,287,605	8,914,718	17,367,974	7,128,342
Summary
Free Cash Flow	-7,645,532	-10,380,677	-11,448,237	-10,116,350	-6,824,821
Net Change in Cash	69,590	-9,090,965	-2,539,476	7,251,624	303,521